平安證券集團控股(00231.HK):呈請人申請的有關供股禁制令已被駁回
格隆匯10月25日丨平安證券集團控股(00231.HK)公告, 於2019年10月22日,公司收到傳票,要求公司出席2019年10月25日(星期五)上午十時正法院聆訊,內容涉及呈請人申請(i)禁制令使公司、全體董事及長青均不得導致公司採取任何步驟以實行、進行、實施及╱或執行有關供股任何其他行動及╱或令公司已發行股出現任何其他變動;或(ii)法院認為合適有關進一步或其他頒令。
於聆訊上,禁制令已被駁回,理由是(其中包括)公司確實需要資金,而公司董事會決定進行供股並非出於不正當目的。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.